May 2021 | Volume 2
If we are truly dedicated to the notion that science leads, we must accelerate the pace at which science translates to practice. COVID taught us that hard lesson, and also showed us ways to achieve nimbleness. We also must recalibrate what science measures and investigates. New and inquisitive research must look at our biological, geographical, and socio-economic differences, and challenge status quo systems to deliver value from the perspective of individuals and families who experience both episodic and life-altering health conditions. It’s painstaking work, but it is essential if we hope to define and deliver world-class care, equitably, to all.
Putting Stakeholder Engagement at the Center of Health Economic Modeling for Health Technology Assessment in the United States
While evidence generated from health economic (HE) models is being used more commonly in health technology assessment (HTA) in the US, it is not consistently adopted by different stakeholder groups or across therapeutic areas.
Luck is not a strategy: The world needs to start preparing now for the next pandemic
As countries grapple with the worst global pandemic in a century, it’s hard to think about preparing for the next one. But if we don’t, it could be worse than Covid-19.
Over the last 30 years, infectious disease outbreaks have emerged with alarming regularity.
A Primary Care Physician for Every American, Science Panel Urges
The federal government must aggressively bolster primary care and connect more Americans with a dedicated source of care, the National Academies of Sciences, Engineering and Medicine warn in a major report that sounds the alarm about an endangered foundation of the U.S. health system.
Epic, Humana ramp up partnership to focus on streamlining prior authorizations
Two years after teaming up to boost data sharing and ease administrative headaches, Epic and Humana are ramping up their partnership to streamline prior authorizations for providers.
Direct-To-Consumer Telemedicine Visits For Acute Respiratory Infections Linked To More Downstream Visits 
Use of direct-to-consumer telemedicine—on-demand virtual care for minor medical issues—is growing rapidly. Although it may yield immediate savings by diverting health care from higher-cost settings, these savings could be countered if direct-to-consumer telemedicine increases follow-up care and, therefore, episode costs.
Op-Ed: Insurers Bet Big on Bribing Patients
Last month, psoriasis patients covered by Cigna received a curious letter from the insurance giant's pharmacy management division. They could receive a $500 debit card from Cigna, with just one string attached: they would have to switch to a different medication, one preferred by the insurer. Shortly thereafter, the patients' treating physicians received a letter containing the same message.
Let’s banish the term ‘patient’ from the health care lexicon
Almost every industry has changed the term for the people they serve. We are now passengers, guests, members, customers, and more. The big exception? Health care. To those in the field, whether it’s clinicians or researchers or pharmaceutical marketers, we are all “patients” — even when we feel fine and aren’t in a hospital or doctor’s office.
Health tech companies form a new coalition to advance the role of real-world data
On Wednesday, five health data analytics companies announced they have banded together to form an industry consortium that aims to transform the way new drugs and devices make their way to patients. 
Healthcare Delivery Disrupted? The Rise Of Platforms In Healthcare
The regulated taxicab industry arose to meet a common but difficult to solve challenge: how to make custom transportation available in a safe, predictable manner. For decades, the taxi industry was a relatively staid one; while it may not have been highly profitable, it was attractive for operators, largely due to the predictability afforded by the protections of limited competition, thanks to local regulators.
Time To Set Aside The Term ‘Low-Value Care’—Focus On Achieving High-Value Care For All
“Low-value care” has been defined as care in which the potential for harm far outweighs possible benefits. When one has the opportunity to consider the phrase in conjunction with its definition, it evokes the notion that patients, their clinicians, and care team are discussing several dimensions of care, weighing the “pros” and “cons,” and arriving at a shared decision.

Passion + Quality = Change That Matters
I embrace the powerful opportunities in our evolving health care landscape. I founded Momentum Health Strategies to be a catalyst for change through continuous learning, diverse engagement and thoughtful policy and practice initiatives. I deliver innovative, strategic thinking and a passion for improving the patient experience. My personal drive and dedication to high-quality results will help you navigate the competitive terrain you face and convert your vision to action.

Momentum Health Strategies

Jennifer L Bright, MPA
(703) 628 - 0534